Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.

Therapeutics

Health Care

Biotechnology

Sapience Therapeutics, Inc.

Barry Kappel

Seth Rubin

Nancy Dong, CMA, SPHR

Marisa Frackman

Jim Rotolo

Gina Capiaux

Gene Merutka

Dana Porrazzo

Research and Development Team

Leadership Team

Teams at Sapience Therapeutics, Inc.

Research and Development Team

Leadership Team